- Home
- KXIN vs SCNI Comparison
KXIN vs SCNI Comparison
Compare KXIN & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KXIN | SCNI |
|---|---|---|
| Founded | 2015 | 2003 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7M | 1.7M |
| IPO Year | 2017 | 2014 |
Fundamental Metrics
Financial Performance| Metric | KXIN | SCNI |
|---|---|---|
| Price | $1.29 | $1.41 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 3.0M | 1.3M |
| Earning Date | 11-26-2019 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 50.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.11 | $0.21 |
| 52 Week High | $22.00 | $3.58 |
Technical Indicators
Market Signals| Indicator | KXIN | SCNI |
|---|---|---|
| Relative Strength Index (RSI) | 30.56 | 45.52 |
| Support Level | $0.42 | $0.40 |
| Resistance Level | $1.28 | $2.67 |
| Average True Range (ATR) | 0.25 | 0.24 |
| MACD | 0.14 | -0.09 |
| Stochastic Oscillator | 15.10 | 1.97 |
Price Performance
Historical ComparisonAbout KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto dealership company mainly engaged in the sale of domestic and imported automobiles in China. The company provides new and used car buyers in China with access to a wide selection of used vehicles across its network of dealerships, with a focus on premium brands such as Audi, BMW, Mercedes-Benz, Land Rover, and Porsche. The company generates revenue from automobile sales and related services.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.